Peptide Series: Is Retatrutide the Next Frontier in Weight Management?

 Medically reviewed by Dr. Dan Wool, NMD

 Arizona-licensed Naturopathic Physician; Hormone, Peptide & Gastroenterology Specialist

 Updated: January 30, 2026

Summary: 

• What Is Retatrutide and How Does It Work? Retatrutide is Eli Lilly's Phase 3 experimental peptide that activates three metabolic receptors—GLP-1 (reduces appetite, slows digestion), GIP (improves insulin response), and glucagon (burns fat and calories)—offering a new option for weight loss compared to predecessors like Semaglutide and Tirzepatide.
• Retatrutide Benefits: Weight Loss and Metabolic Health Clinical trials show 24% body weight loss over 48 weeks—more than any approved medication in its class—while potentially preserving muscle mass and avoiding "Semaglutide face." It improves insulin sensitivity, blood sugar levels, cholesterol, and may help comorbid conditions like sleep apnea and knee osteoarthritis through reduced inflammation.
• Retatrutide Side Effects and Limitations Not FDA-approved and only available through medical trials; common digestive side effects include nausea, vomiting, and diarrhea that often improve over time. Long-term safety regarding pancreatic health, thyroid function, and cardiovascular effects remains unknown pending Phase 3 completion.
• Retatrutide Requires a Comprehensive Lifestyle Plan Not a quick fix—like GLP-1 predecessors, stopping medication can cause massive rebound weight gain without a solid plan. Success requires combining peptide therapy with healthy diet, exercise, stress management, regular medical monitoring of blood sugar, liver function, and thyroid levels, plus personalized naturopathic support.

Introduction: Peptides and Their Expanding Role in Wellness

Peptides have become a big buzzword in both traditional and naturopathic medicine and the wellness industry. They have gained traction in the past decade and have become mainstream in the last few years.

The most commonly known peptides on the market presently are called GLP-1 agonists, a category in which Retatrutide complements. Initially created to treat diabetes, GLP-1 targeting medications have been used off-label for several years to help manage metabolism and obesity. 

For context, here are some quick (and hopefully helpful) definitions to inform our Retatrutide discussion: 

• Peptides are short chains of amino acids that act as signaling molecules in the body. As a result, they can influence everything from hormone regulation to immune function.
• GLP-1: The most commonly known peptides are called GLP-1 Agonists. GLP stands for Glucagon-like Peptide. The 1 is the number of a specific cell surface receptor.
  
• Glucagon, which is produced in the pancreas,  is the body's signaling hormone that helps to raise blood sugar (glucose) when it's too low. (Because glucose is the body's primary fuel source, your brain likes to keep glucose levels in a tight window; we don't want too much, which causes inflammation; and we don't want too little, which impairs brain and bodily function).
• Insulin: You also may have heard of insulin, which helps to remove blood sugar from circulation and put it to use - like a fuel injector in a car. People with diabetes (for whom GLP-1 meds were initially invented to treat), have chronically low insulin, which creates chronically and often, dangerously, high blood sugar. 
• GIP stands for Gastric Inhibitory Peptide helps to regulate glucose and fat metabolism. It helps to stimulate insulin release from the pancreas. 
• Agonist means the medication or therapy pushes a receptor or organ to do something, perhaps more than usual, to achieve an outcome.
• Antagonist means it blocks function in order to achieve a specific outcome).

What Is Retatrutide?

Retatrutide is among the newest and most promising peptides in the realm of metabolic health. It’s a multi-receptor agonist currently under clinical investigation for treating obesity and related conditions.

GLP-1 (Single Receptor) Predecessors to Retatrutide

Earlier peptide therapies, such as Semaglutide and Tirzepatide would target a single receptor; however, Retatrutide is designed to activate three key receptors involved in metabolism: GLP-1, GIP, and glucagon. This triple-action approach has caused excitement in the medical community for its potential to deliver unprecedented weight loss and metabolic benefits with fewer side effects from the single receptor versions [1].

Retatrutide is an experimental medication being developed by Eli Lilly & Co. - currently in Stage 3 (the latest stage) trials. It’s part of a new generation of treatments designed to help with weight loss, blood sugar control, and possibly other health issues like sleep apnea and joint problems.

What makes Retatrutide unique is that it is designed to work on three different hormone systems in the body at the same time. These hormones play a big role in how we manage hunger, store fat, and regulate blood sugar. By targeting all three, Retatrutide aims to deliver stronger and more balanced results than older medications that only focus on one.

How Retatrutide works

• GLP-1 (Glucagon-like peptide-1): This hormone helps your body release insulin when needed, slows down how quickly food (and thus glucose) leaves your stomach, and helps you feel full sooner—so you naturally eat less.
• GIP (Glucose-dependent insulinotropic polypeptide): This one works alongside GLP-1 to improve how your body responds to insulin, which helps keep blood sugar levels stable.
• Glucagon receptor: Activating this receptor helps your body burn more calories and fat, even when you're at rest.

Because Retatrutide acts on all three of these systems, it’s being studied not just for weight management, but also for its potential to improve metabolic health more broadly. Early research suggests it could be especially helpful for people with type 2 diabetes, obesity, or related conditions. [2]

Main Benefits of Retatrutide

Retatrutide is showing exciting potential in early studies, especially when it comes to helping people lose weight and improve overall health. Here are some of the key benefits researchers have seen so far:

1. Like GLP-1's Retatrutide Fosters Impressive Weight Loss

In clinical trials, Retatrutide helped participants lose more weight than any currently approved medication in its class—including Tirzepatide. In one study, people lost up to 24% of their body weight over the course of 48 weeks [1].  Notably common side effects from Semaglutide and Tirzepatide seem mitigated with Retatrutide.

With the predecessor peptides, people would lose weight from everywhere, quickly and often dramatically, including usually untouched pockets of fat and muscle, leading to effects like "Semaglutide Face" [4]. Anecdotally, early signs from Retatrutide suggests that the triple-action approach helps patients retain muscle mass, while still, and perhaps more steadily, losing fat[1]. This is a significant change that could make a real difference in someone’s health and quality of life.

2. Retatrutide Trials Suggest Better Metabolic Health

Retatrutide also appears to improve several important health markers, including:

• Insulin sensitivity (how well your body uses insulin - diabetics and those with metabolic syndromes have "insulin resistance" which causes blood sugar that's too high)
• Blood sugar levels
• Cholesterol and other blood fats

These improvements could make Retatrutide a strong option for managing conditions like type 2 diabetes, metabolic syndrome, and heart disease risk [3].

3. Retatrutide Could Offer Help for Related (Comorbid) Obesity Conditions

Researchers are also looking into how Retatrutide might help with other health issues that often go hand-in-hand with obesity, such as:

• Sleep apnea (a condition that affects breathing during sleep)
• Knee osteoarthritis (joint pain and stiffness)

Because Retatrutide may reduce inflammation and support weight loss, it could offer relief for these conditions too [2].

Retatrutide Drawbacks and Limitations

Like any new treatment, Retatrutide may come with some potential downsides and unknowns:

1. Retatrutide Can Have Digestive Side Effects

Some people in clinical trials experienced stomach-related symptoms like:

• Nausea
• Vomiting
• Diarrhea

These side effects often depend on the dose and may improve over time as the body adjusts. It’s always best to consult with a healthcare provider or a naturopath before taking on a course of any other medication or supplement, and since

2. Retatrutide Is Not FDA-approved or Widely Available

Retatrutide is not yet approved by the FDA. That is, one can only get it via medical trials. That means it’s not something you can get from your doctor or use in medical practice just yet. And while experts know what it does, at the end of the day, trials are not yet complete and results are not standard. 

3. Retatrutide's Long-Term Safety Is Still Unknown

Since Retatrutide is still being studied, we don’t yet know how it affects the body in the long run. Researchers are keeping a close eye on things like:

• Pancreatic health
• Thyroid function
• Heart safety

These questions are being explored in ongoing Phase 3 clinical trials.

Retatrutide: Important Things to Keep in Mind

1. Retatrutide Would Not Be a Quick Fix 

While Retatrutide shows a lot of promise, it will not be a magic bullet. Healthy people might use it as a tool for weight loss, but when the course of medication is over - then what? One risk with GLP-1 meds is massive rebound weight gain once they went off the medication.  Like any health tool, it will work best when combined with a healthy lifestyle and a balanced diet. That means eating well, staying active, managing stress, and getting good sleep are still essential for long-term success on any GLP-1-type peptide.

2. Everyone May Respond Differently 

Not all bodies react the same way to peptide therapies. One's genes, gut health, and existing medical conditions can all influence how well it works for you. That’s why a personalized and detailed review of your lifestyle and medical history is so important.

3. With Retatrutide, Regular Doctor Check-ins Are Key

If Retatrutide becomes available in the future, it will be important to monitor your health regularly. This includes checking things like side effects, blood sugar, peptide markers, liver function, and thyroid levels to make sure the treatment is working safely and effectively.

What to Expect If You’re Exploring Peptide Therapy

Even though Retatrutide isn’t available outside of clinical trials yet, it represents a new wave of treatments that target multiple systems in the body at once. If you’re considering GLP-1 peptide therapy with your naturopathic provider for weight loss, here’s what the process might look like:

• Initial Evaluation: You’ll start with a full health assessment, including your metabolism, hormone levels, and lifestyle habits.
• Tailored Treatment Plan: Your provider may combine peptides with supplements, nutrition changes, and other therapies to support your goals.
• Slow and Steady Dosing: Peptides are usually introduced gradually to reduce the risk of side effects.
• Ongoing Support: You’ll have regular check-ins and lab tests to track your progress and fine-tune your plan as needed.

The Bottom Line on Retatrutide

Retatrutide represents a new generation of peptide therapy that could redefine how we approach obesity and metabolic disorders. Its triple-receptor mechanism, targeting three hormone systems in the body, offers enhanced weight loss and metabolic benefits. Still, it also comes with unknowns and limitations that require caution at this stage. 

For those interested in peptide therapy, Retatrutide is a promising development to keep an eye on. As research continues, it may become a valuable tool in both conventional and naturopathic care, especially when integrated into a holistic wellness plan.

Frequently Asked Questions About Retatrutide

1. How is Retatrutide different from Ozempic or Wegovy (semaglutide)?

Retatrutide targets three hormone receptors (GLP-1, GIP, and glucagon) versus Ozempic's (semaglutide's) single receptor. Clinical trials show up to 24% weight loss with Retatrutide compared to lower percentages with single-receptor medications, plus better muscle retention and potentially fewer side effects. That said, it's still in clinical trials and not widely available, thus Semaglutide and Tirzepatide are more available options at this time. 

2. What should I do to prepare for Retatrutide or any peptide weight loss therapy?

I recommend starting with a comprehensive health evaluation including metabolic markers, hormone levels and lifestyle assessment. Work with your naturopathic physician to optimize nutrition, establish exercise habits and address gut health, creating a foundation for successful peptide therapy when appropriate options become available.

Are GLP-1 Weight Loss Peptides Right for You? 

Dr. Dan Wool believes in the use of scientifically-backed peptide therapies to enhance patient outcomes for weight loss. Retatrutide is a potential therapy option under study for those struggling with weight loss, metabolic balance and stalled fitness goals. If these sound familiar, it may be time to explore a full health assessment from Dr. Wool. Book a free 15 Minute Discovery Call to understand how GLP-1 weight loss peptides might fit into your treatment plan to help restore balance from the inside out.

Interested in learning more? Contact us today to see if GLP-1 peptide aided weight loss therapy is right for you

Disclaimer:

For educational purposes only — not medical advice, diagnosis, treatment or advertising for consumer purchase. Dr. Dan Wool and affiliates make no effectiveness claims about supplements, hormones, peptides or other therapeutics beyond cited clinical evidence and regulatory approval. Compounded peptide therapies may be prescribed off-label by licensed providers when clinically appropriate; they are not FDA-approved for general consumer use, retail sale or recreational self‑administration and are dispensed exclusively through licensed pharmacies to patients under active clinical care. Regulatory status varies across medical, retail and athletic contexts. Always consult a qualified healthcare provider before starting, changing, or stopping any medical or wellness program.

Learn more about specific Peptides

References:

[1] Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & Kushner, R. F. (2023). Triple-hormone receptor agonist Retatrutide in obesity. *New England Journal of Medicine*. https://www.nejm.org/doi/full/10.1056/NEJMoa2301972

[2] Eli Lilly and Company. (2023). Retatrutide (LY3437943) Fact Sheet. https://investor.lilly.com/news-releases/news-release-details/lillys-retatrutide-achieved-up-24-weight-loss-phase-2-study

[3] American Diabetes Association. (2023). Incretin-Based Therapies and Metabolic Health. https://diabetes.org/newsroom/press-releases/2023/incretin-based-therapies-and-metabolic-health

[4] Journal of Facial Plastic Surgery, 2023 "Implications of Ozempic and Other Semaglutide Medications for Facial Plastic Surgeons. Dec;39(6):719-721. doi: 10.1055/a-2148-6321. Epub 2023; retrieved 8/4/25 from: https://pubmed.ncbi.nlm.nih.gov/37541662/